Barriers to participation in industry‐sponsored clinical trials in pediatric type 2 diabetes
Sign Up to like & getrecommendations! Published in 2017 at "Pediatric Diabetes"
DOI: 10.1111/pedi.12465
Abstract: The rapid emergence of type 2 diabetes (T2D) in the pediatric population has left pediatric endocrinologists with limited artillery in terms of management. While multiple medications are available for adults, Food and Drug Administration (FDA)‐approved… read more here.
Keywords: barriers participation; type diabetes; industry sponsored; diabetes barriers ... See more keywords